SCHEMBL17077824

SCHEMBL17077824

Nc1nc2c(c(C(F)(F)F)n1)OCCN2

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 1/20 0.32
▸ AKT1S1 Q96B36 1/20 0.31
▸ DHFR P00374 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30278034 0.71 DHFR (0.34) DHFR
SCHEMBL30278050 0.66 DHFR (0.32) DHFR
SCHEMBL30412014 0.66 AR (0.39) DHFR
SCHEMBL30278060 0.63 DHFR (0.33) DHFR
SCHEMBL17362435 0.62 RET (0.46) RETAKT1S1
SCHEMBL30698015 0.61 GRM5 (0.40) DHFR
SCHEMBL30698038 0.61 GRM5 (0.40) DHFR
SCHEMBL24175682 0.60 RET (0.32) RET
SCHEMBL24568075 0.59 RET (0.33) RET
SCHEMBL17077911 0.58 GRM5 (0.38) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015138689-A1 FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF FORUM PHARMACEUTICALS INC. (US) 2015-09-17 — — WO disclosed
Send feedback